Categories
Research - Pulmonary Oedema
Whole body and right lung bioimpedance are more sensitive than proximal bioimpedance at predicting response to intravenous furosemide in patients with acute pulmonary oedema
Bioimpedance (Ω) analysis (BIA) provides a potential measure of body water (1). BIA may predict decompensation in systolic heart failure (2). We tested the utility of BIA in assessing the acute response to intravenous furosemide (ivF) in pulmonary oedema.
Comparing sensitivity of non-invasive markers of volume response to intravenous furosemide in patients with acute pulmonary oedema
Intravenous furosemide (ivF) remains the first line treatment for pulmonary oedema (1) yet individual patient response to ivF is variable (2, 3). There is a need for an accurate, non-invasive means to define volume response to ivF, so that the role of alternative or additional treatments can be addressed.
Anti-fibrinolytic Agents & Lung Water in Cardiac Surgical Patients Interim results of a prospective randomised double blind placebo controlled trial
We report the interim results of a prospective randomised double-blind placebo controlled trial of aprotinin v. tranexamic acid v. placebo using a novel device that can measure impedance noninvasively to attempt to give trends in extra-cellular lung water over time.